QCM
TMDX icon

Qsemble Capital Management’s Transmedics TMDX Stock Holding History

Qsemble Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,628
Closed -$519K – 619
2025
Q3 		$519K Buy
+4,628
New +$542K 0.05% 325

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Qsemble Capital Management's TMDX Position: Q4 2025 in Review

Qsemble Capital Management sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 4,628 shares — an estimated $519K sold.

Qsemble Capital Management first reported a position in TMDX in Q3 2025 and held it in 1 quarter. The position peaked at $519K in Q3 2025. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Qsemble Capital Management reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Qsemble Capital Management sold 4,628 Transmedics shares in Q4 2025, an estimated $519K.
  • Qsemble Capital Management first reported a position in Transmedics in Q3 2025 and held it in 1 quarter.
  • Qsemble Capital Management's Transmedics position peaked at $519K in Q3 2025.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Qsemble Capital Management's 13F filing for Q4 2025, filed 5 Feb 2026.